NCT03134300View on ClinicalTrials.gov

Cytokine Persistence as a Marker of Inflammation in the at Risk, Low Socioeconomic Status Pediatric Population

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Obstructive Sleep Apnea of Child

Interventions

DIAGNOSTIC_TEST

Cytokine from blood

Blood draw- one intraoperative, one 3 weeks postoperative

Trial Locations (1)

77030

Texas Childrens Hospital, Houston

All Listed Sponsors

lead

Baylor College of Medicine

OTHER

NCT03134300 - Cytokine Persistence as a Marker of Inflammation in the at Risk, Low Socioeconomic Status Pediatric Population | Biotech Hunter | Biotech Hunter